Total Number of Communication Reports: 0
Monthly communication reports in the last 6 months: 0
Version 2 of 6 (2006-05-11 to 2006-12-22) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
Consultant lobbyist name: | Robert Gabor Lobbyist business address |
Consulting firm: |
Aikins MacAulay & Thorvaldson
30th Floor 360 Main Street Winnipeg, MB R3C 4G1 Canada |
Position: | Partner |
Telephone number: | 204-957-4642 |
Fax number: | 204-957-4283 |
Former public office holder: | Yes |
Payment is contingent on the success of the undertaking: | No |
Client: |
Biomedical Commercialization Canada Inc.
445 Ellice Ave. Winnipeg, MB R3B 3P5 Canada |
||||||
Telephone number: | 204-989-2341 | ||||||
Client Representative: |
Wery
Joe
|
||||||
Parent: | The client is not a subsidiary of any other parent companies. | ||||||
Coalition: | The client is not a coalition. | ||||||
Subsidiary: | The client does not have any subsidiaries that could be affected by the outcome of the undertaking. | ||||||
Individual, organization or corporation: | The client's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. | ||||||
Was the client funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | Yes | ||||||
End date of the client's last completed financial year: | 2005-12-31 | ||||||
|
Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Industry Canada, National Research Council (NRC), Western Economic Diversification Canada (WD) | ||||
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||
Subject Matter: Areas of Concern: | Industry, Intellectual Property, Science and Technology | ||||
Details Regarding the Identified Subject Matter
|